UBS analyst Joshua Spector raised the firm’s price target on FMC (FMC) to $45 from $41 and keeps a Neutral rating on the shares. Better than feared tariff impacts could support downstream firms in the quarter, while commodities are likely to remain under pressure with weaker demand trends, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on FMC:
- Cautious Hold Rating for FMC Amid Uncertainties and Growth Opportunities
- FMC price target raised to $49 from $48 at Barclays
- FMC announces regulatory approval for Tremisia fungicide in Ukraine
- DoorDash, AMD upgraded: Wall Street’s top analyst calls
- Wells upgrades FMC to Overweight on confidence in earnings bottom